May 18, 2026: FDA warns 503B compounding pharmacy for producing tirzepatide after shortage ended Major Stories Read FDA's warning letter The FDA issued a warning letter to ProRx, citing its production of tirzepatide, which is not eligible for compounding
Pure Med Spa Chicago provides transparent information and affordable payment options
The FDA and patients have been caught in the middle of a fight between the makers of branded drugs used to treat obesity and pharmacies that have been compounding cheaper versions of those drugs for more than two years
Ozempic is the most popular GLP-1 medication in the US, with the highest share of prescriptions in 2024
Get it wrong, and you either waste expensive peptide or underdose yourself during the most critical phase of your protocol
Eat upright, avoid lying down for a few hours after meals, and consider smaller dinners